Literature DB >> 17686468

Evidence for differential changes of junctional complex proteins in murine neurocysticercosis dependent upon CNS vasculature.

Jorge I Alvarez1, Judy M Teale.   

Abstract

The delicate balance required to maintain homeostasis of the central nervous system (CNS) is controlled by the blood-brain barrier (BBB). Upon injury, the BBB is disrupted compromising the CNS. BBB disruption has been represented as a uniform event. However, our group has shown in a murine model of neurocysticercosis (NCC) that BBB disruption varies depending upon the anatomical site/vascular bed analyzed. In this study further understanding of the mechanisms of BBB disruption was explored in blood vessels located in leptomeninges (pial vessels) and brain parenchyma (parenchymal vessels) by examining the expression of junctional complex proteins in murine brain infected with Mesocestoides corti. Both pial and parenchymal vessels from mock infected animals showed significant colocalization of junctional proteins and displayed an organized architecture. Upon infection, the patterned organization was disrupted and in some cases, particular tight junction and adherens junction proteins were undetectable or appeared to be undergoing proteolysis. The extent and timing of these changes differed between both types of vessels (pial vessel disruption within days versus weeks for parenchymal vessels). To approach potential mechanisms, the expression and activity of matrix metalloproteinase-9 (MMP-9) were evaluated by in situ zymography. The results indicated an increase in MMP-9 activity at sites of BBB disruption exhibiting leukocyte infiltration. Moreover, the timing of MMP activity in pial and parenchymal vessels correlated with the timing of permeability disruption. Thus, breakdown of the BBB is a mutable process despite the similar structure of the junctional complex between pial and parenchymal vessels and involvement of MMP activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17686468      PMCID: PMC2754301          DOI: 10.1016/j.brainres.2007.07.010

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  75 in total

Review 1.  Structural and signalling molecules come together at tight junctions.

Authors:  S Tsukita; M Furuse; M Itoh
Journal:  Curr Opin Cell Biol       Date:  1999-10       Impact factor: 8.382

Review 2.  Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier.

Authors:  J D Huber; R D Egleton; T P Davis
Journal:  Trends Neurosci       Date:  2001-12       Impact factor: 13.837

Review 3.  Molecular and cellular permeability control at the blood-brain barrier.

Authors:  S M Gloor; M Wachtel; M F Bolliger; H Ishihara; R Landmann; K Frei
Journal:  Brain Res Brain Res Rev       Date:  2001-10

Review 4.  Glial cell influence on the human blood-brain barrier.

Authors:  A Prat; K Biernacki; K Wosik; J P Antel
Journal:  Glia       Date:  2001-11       Impact factor: 7.452

Review 5.  The JAM family of proteins.

Authors:  Kenneth J Mandell; Charles A Parkos
Journal:  Adv Drug Deliv Rev       Date:  2005-04-25       Impact factor: 15.470

Review 6.  The blood-brain barrier/neurovascular unit in health and disease.

Authors:  Brian T Hawkins; Thomas P Davis
Journal:  Pharmacol Rev       Date:  2005-06       Impact factor: 25.468

Review 7.  In search of the astrocytic factor(s) modulating blood-brain barrier functions in brain capillary endothelial cells in vitro.

Authors:  R F Haseloff; I E Blasig; H C Bauer; H Bauer
Journal:  Cell Mol Neurobiol       Date:  2005-02       Impact factor: 5.046

8.  Reduced expression of junctional adhesion molecule and platelet/endothelial cell adhesion molecule-1 (CD31) at human vascular endothelial junctions by cytokines tumor necrosis factor-alpha plus interferon-gamma Does not reduce leukocyte transmigration under flow.

Authors:  S K Shaw; B N Perkins; Y C Lim; Y Liu; A Nusrat; F J Schnell; C A Parkos; F W Luscinskas
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

Review 9.  An update on the neuropathology of HIV in the HAART era.

Authors:  J E Bell
Journal:  Histopathology       Date:  2004-12       Impact factor: 5.087

10.  MMP-2 null mice exhibit an early onset and severe experimental autoimmune encephalomyelitis due to an increase in MMP-9 expression and activity.

Authors:  Jordi Esparza; Meghan Kruse; Janet Lee; Michael Michaud; Joseph A Madri
Journal:  FASEB J       Date:  2004-11       Impact factor: 5.191

View more
  21 in total

Review 1.  Inflammatory cell trafficking across the blood-brain barrier: chemokine regulation and in vitro models.

Authors:  Yukio Takeshita; Richard M Ransohoff
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

2.  Multiple expression of matrix metalloproteinases in murine neurocysticercosis: Implications for leukocyte migration through multiple central nervous system barriers.

Authors:  Jorge I Alvarez; Judy M Teale
Journal:  Brain Res       Date:  2008-04-01       Impact factor: 3.252

Review 3.  Immunologic privilege in the central nervous system and the blood-brain barrier.

Authors:  Leslie L Muldoon; Jorge I Alvarez; David J Begley; Ruben J Boado; Gregory J Del Zoppo; Nancy D Doolittle; Britta Engelhardt; John M Hallenbeck; Russell R Lonser; John R Ohlfest; Alexandre Prat; Maurizio Scarpa; Richard J Smeyne; Lester R Drewes; Edward A Neuwelt
Journal:  J Cereb Blood Flow Metab       Date:  2012-10-17       Impact factor: 6.200

4.  T1-weighted dynamic contrast-enhanced MR evaluation of different stages of neurocysticercosis and its relationship with serum MMP-9 expression.

Authors:  R K Gupta; R Awasthi; R K Garg; N Kumar; P K Gupta; A K Singh; P Sahoo; V K Paliwal; K N Prasad; C M Pandey; R K S Rathore
Journal:  AJNR Am J Neuroradiol       Date:  2012-11-22       Impact factor: 3.825

5.  STAT6⁻/⁻ mice exhibit decreased cells with alternatively activated macrophage phenotypes and enhanced disease severity in murine neurocysticercosis.

Authors:  Bibhuti B Mishra; Uma Mahesh Gundra; Judy M Teale
Journal:  J Neuroimmunol       Date:  2010-11-03       Impact factor: 3.478

6.  Increased disease severity of parasite-infected TLR2-/- mice is correlated with decreased central nervous system inflammation and reduced numbers of cells with alternatively activated macrophage phenotypes in a murine model of neurocysticercosis.

Authors:  Uma Mahesh Gundra; Bibhuti B Mishra; Kondi Wong; Judy M Teale
Journal:  Infect Immun       Date:  2011-04-11       Impact factor: 3.441

7.  MyD88-deficient mice exhibit decreased parasite-induced immune responses but reduced disease severity in a murine model of neurocysticercosis.

Authors:  Bibhuti B Mishra; Uma Mahesh Gundra; Kondi Wong; Judy M Teale
Journal:  Infect Immun       Date:  2009-09-28       Impact factor: 3.441

8.  Increased accumulation of regulatory granulocytic myeloid cells in mannose receptor C type 1-deficient mice correlates with protection in a mouse model of neurocysticercosis.

Authors:  Pramod Kumar Mishra; Elizabeth G Morris; Jenny A Garcia; Astrid E Cardona; Judy M Teale
Journal:  Infect Immun       Date:  2013-01-14       Impact factor: 3.441

Review 9.  How do immune cells support and shape the brain in health, disease, and aging?

Authors:  Michal Schwartz; Jonathan Kipnis; Serge Rivest; Alexandre Prat
Journal:  J Neurosci       Date:  2013-11-06       Impact factor: 6.167

10.  Doxycycline treatment decreases morbidity and mortality of murine neurocysticercosis: evidence for reduction of apoptosis and matrix metalloproteinase activity.

Authors:  Jorge I Alvarez; Janani Krishnamurthy; Judy M Teale
Journal:  Am J Pathol       Date:  2009-07-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.